Cite
HARVARD Citation
Herrmann, S. (2022). Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO. Kidney360. 3 (5), pp. 799-802. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Herrmann, S. (2022). Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO. Kidney360. 3 (5), pp. 799-802. [Online].